Goldman Opens QGEN With Sell

Analysts at Goldman initiate coverage of Qiagen NV QGEN with a “sell” rating. The target price for QGEN is set to $18. QGEN shares fell 0.10% to close at $20.40 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsGoldmanHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!